Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
fda
3
×
life sciences
national blog main
national top stories
3
×
new york top stories
san francisco top stories
boston blog main
boston top stories
new york blog main
san diego blog main
san diego top stories
san francisco blog main
aimmune therapeutics
akcea therapeutics
allergy
alnylam pharmaceuticals
anaphylaxis
andrew oxtoby
barry greene
billy dunn
biogen
boston
boston university
boulder/denver blog main
boulder/denver top stories
dan ollendorf
daniel edelman
detroit blog main
detroit top stories
drug prices
drug pricing
drugs
eosinophilic esophagitis
europe top stories
evrysdi
food allergy
gene therapy
genentech
What
fda
friday
3
×
approved
drug
medicine
oral
patients
therapy
time
agency
ago
aimmune
allergy
alnylam
approval
approve
atrophy
awaits
awarded
biological
crossed
daily
decades
decision
developed
discovered
evrysdi
fingers
green
historic
home
immunotherapy
intended
late
lights
liquid
muscular
new
peanut
risdiplam
Language
unset
Current search:
friday
×
fda
×
" national top stories "
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision